Search global stocks & ETFs...Ctrl K
Learn Mode
BRKR
Stock Profile
08-03
Recommended Metric
Score Card
Explore Scores Tab
2.50
Bad
Valuation Score
Key Score
5.00
Very Good
Management
4.00
Good
Growth
2.00
Bad
Profitability
2.00
Bad
Fin. Health
2.00
Bad
Dividends
1.00
Very Bad
Analyst
5.00
Very Good
Insider Transactions
Explore Insider Tab ›Buy Transactions
Sell Transactions
Peers
Select stocks to compare
Price Targets & Ratings
View Analysis
1-year price targets, ending May 11, 2027
Current
$61.34
Baseline
High
$63.00
▲
2.71%
Avg
$49.07
▼
-20.00%
Low
$35.35
▼
-42.37%
Analyst Ratings based on 22 Analysts
Strong Buy
732%
Buy
732%
Hold
732%
Sell
105%
Strong Sell
000%
Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company is headquartered in Billerica, Massachusetts and currently employs 11,085 full-time employees. The company went IPO on 2000-08-04. The firm's segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). Its BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research and development solutions in chemical research fields. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and others.Read More